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Abstract
During submaximal exercise fatty acids are a predominant energy source for
muscle contractions. An important regulator of fatty acid oxidation is acetyl-
CoA carboxylase (ACC), which exists as two isoforms (ACC1 and ACC2) with
ACC2 predominating in skeletal muscle. Both ACC isoforms regulate malo-
nyl-CoA production, an allosteric inhibitor of carnitine palmitoyltransferase 1
(CPT-1); the primary enzyme controlling fatty acyl-CoA flux into mitochon-
dria for oxidation. AMP-activated protein kinase (AMPK) is a sensor of cellu-
lar energy status that is activated during exercise or by pharmacological agents
such as metformin and AICAR. In resting muscle the activation of AMPK
with AICAR leads to increased phosphorylation of ACC (S79 on ACC1 and
S221 on ACC2), which reduces ACC activity and malonyl-CoA; effects associ-
ated with increased fatty acid oxidation. However, whether this pathway is
vital for regulating skeletal muscle fatty acid oxidation during conditions of
increased metabolic flux such as exercise/muscle contractions remains
unknown. To examine this we characterized mice lacking AMPK phosphoryla-
tion sites on ACC2 (S212 in mice/S221 in humans-ACC2-knock-in [ACC2-
KI]) or both ACC1 (S79) and ACC2 (S212) (ACC double knock-in [ACCD-
KI]) during submaximal treadmill exercise and/or ex vivo muscle contractions.
We find that surprisingly, ACC2-KI mice had normal exercise capacity and
whole-body fatty acid oxidation during treadmill running despite elevated
muscle ACC2 activity and malonyl-CoA. Similar results were observed in
ACCD-KI mice. Fatty acid oxidation was also maintained in muscles from
ACC2-KI mice contracted ex vivo. These findings indicate that pathways inde-
pendent of ACC phosphorylation are important for regulating skeletal muscle
fatty acid oxidation during exercise/muscle contractions.
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Introduction
The AMP-activated protein kinase (AMPK) is an evolu-
tionarily conserved metabolic stress-sensing kinase that
is rapidly activated in response to muscle contractions
in both rodents and humans (for review see O’Neill
2013). In skeletal muscle the activation of AMPK is
proposed to restore energy balance by switching on
ATP-producing pathways such as glucose uptake and
fatty acid oxidation. The role of AMPK in regulating
skeletal muscle fatty acid oxidation has been studied
intensively using the pharmacological agent 5-aminoimi-
dazole-4-carboxamide ribonucleotide (AICAR) (Munday
et al. 1988a,b; Merrill et al. 1997; Koistinen et al. 2003;
Dzamko et al. 2008). AICAR increases skeletal muscle
AMPK activity and reduces the activity of acetyl-CoA-
carboxylase 2 (ACC2). Reductions in ACC2 activity are
associated with lower muscle malonyl-CoA, which is an
allosteric inhibitor of carnitine palmitoyl transferase
(CPT)-I; the rate-limiting enzyme that controls the
transfer of cytosolic long-chain fatty acyl-CoAs into the
mitochondria for b oxidation (Winder and Hardie
1996; Rasmussen and Winder 1997). Consistent with an
important role for ACC2 in regulating skeletal muscle
fatty acid oxidation some (Abu-Elheiga et al. 2001;
Hoehn et al. 2010) but not all (Olson et al. 2010) stud-
ies have shown that mice deficient in ACC2 have
higher rates of skeletal muscle fatty acid oxidation. In
agreement with an important role for ACC2 in skeletal
muscle, mice with a targeted knock-in mutation to the
AMPK phosphorylation site on ACC2 (S212 in mice
which is the equivalent to S221 in humans) are insensi-
tive to AICAR-stimulated increases in fatty acid oxida-
tion (O’Neill et al. 2014).
Despite the compelling evidence indicating a vital role
for AICAR to regulate skeletal muscle fatty acid oxida-
tion via an AMPK-ACC2-dependent pathway, the
importance of this pathway for increasing fatty acid oxi-
dation during exercise/muscle contraction is not clear.
For example, rates of fatty acid oxidation increase until
~65% of maximal oxygen uptake (Jeukendrup 2002);
however, AMPK and ACC phosphorylation are only par-
tially increased at these low exercise intensities and
malonyl-CoA content is unchanged or only modestly
reduced (Odland et al. 1996; Roepstorff et al. 2005). In
contrast, during high-intensity exercise, where carbohy-
drates are preferentially utilized and absolute rates of
fatty acid oxidation actually decline (Romijn et al.
1995), AMPK is potently activated but malonyl-CoA lev-
els do not change (Odland et al. 1998). Similarly,
AMPK activity and ACC phosphorylation is reduced in
trained versus untrained humans and rodents despite
their greater utilization of fatty acids during exercise at
the same absolute or relative workload (Durante et al.
2002; McConell et al. 2005). Consistent with a mismatch
between AMPK activity and fatty acid oxidation during
exercise/muscle contractions, mice that have reductions
in skeletal muscle AMPK activity appear to have normal
(Dzamko et al. 2008; Steinberg et al. 2010; Jeppesen
et al. 2013) or slightly higher rates of fatty acid oxida-
tion (O’Neill et al. 2011) during exercise; although it
should be noted that a very recent report has found
that AMPK a muscle null mice have a higher RER
(indicative of lower whole-body fatty acid oxidation)
during treadmill exercise and a modest reduction in
contraction-stimulated fatty acid oxidation in soleus
muscle (Fentz et al. 2015). Surprisingly, despite large
reductions in muscle AMPK activity in all of the above
mouse models there are increases in the phosphorylation
of ACC2 during exercise/muscle contractions; thus mak-
ing it difficult to determine the importance of ACC2
phosphorylation for controlling fatty acid oxidation.
Therefore, the purpose of this study was to assess
fatty acid oxidation in mice lacking the AMPK phos-
phorylation site on ACC2 (ACC2-KI). To examine
potential compensation by ACC1, which is expressed at
extremely low levels in muscle but has been suggested to
possibly compensate for a lack of ACC2 (Olson et al.
2010), we also studied mice lacking the AMPK phos-
phorylation site on both ACC1 and ACC2 (ACCD-KI).
We hypothesized that during exercise/muscle contrac-
tions ACC2-KI and ACCD-KI mice would have
impaired rates of fatty acid oxidation due to elevated
ACC2 activity and malonyl-CoA, which would reduce
endurance exercise capacity and/or muscle performance.
Surprisingly, we found that while ACC2 S212 phosphor-
ylation is important for reducing ACC2 activity and
malonyl-CoA levels during exercise this appears to have
little bearing on rates of skeletal muscle fatty acid oxida-
tion, thus providing evidence that ACC2-independent
pathways are capable of regulating fatty acid oxidation
during muscle contractions.
Methods
Mice- environment and diet
ACC2 S212A KI (ACC2-KI) and ACC1/2 KI (ACC-DKI)
mice have been recently described (Fullerton et al. 2013).
Male mice were housed in Specific Pathogen Free microis-
olators and maintained under control environment condi-
tions (12 h/12 h light–dark cycle with lights on at 07:00
and temperature of 23°C). Mice had ad libitum access to
water and standard chow diet (17% kcal fat; Diet 8640,
Harlan Teklad, Madison, WI) until experiments were
completed between 10 and 16 weeks of age. All experi-
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ments were approved by the McMaster University and St.
Vincent’s Hospital, Animal Ethics Committees.
Blood analyses
Mice were exercised (60 min at 65% maximal running
speed) before whole-blood samples were taken from tail
blood at 0, 30, and 60 min during exercise, and placed
on ice in tubes containing EDTA before centrifugation at
1830 g for 10 min at 4°C and collection of plasma.
Plasma was stored at 80°C before use in analyses. Blood
glucose was determined by glucometer (Accu-Check,
Roche Diagnostics, Milpitas, Germany). Plasma nonesteri-
fied free fatty acids (NEFA) and lactate were assessed by
colorimetric analysis using a nonesterified fatty acid
(NEFA) (Wako Chemicals, Osaka, Japan) and L-lactate
(Biovision, Milpitas, CA) kits, respectively, adapted for
use in a 96 well microplate. Microplates were read using
a Polarstar Optima microplate reader.
Treadmill exercise
Prior to treadmill running experiments, mice were accli-
matized as recently described (O’Neill et al. 2014). For
maximal exercise capacity testing, mice ran at a 5 degree
gradient at 10 m/min for 2 min before intensity (run-
ning speed) was increased by 1 m/min every 2 min until
mice could not be prompted to continue running by
bottle brushes and electric shockers at the back of the
treadmill (i.e., “exhaustion”). For endurance capacity
testing, mice were run at 65% of their maximal running
capacity at a 5° inclination until exhaustion. The follow-
ing week, VO2, VCO2, RER, and % substrate utilized
were determined by running mice at 65% of maximal
running speed in an enclosed Oxymax treadmill
(Columbus Instruments, Columbus, OH) for 60 min.
Total lipids oxidized during exercise were determined by
calculating mean fatty acid oxidation rate ((1.6946*O2)
(1.7012*VCO2)) (mg/kg/h) (Frayn 1983).
Palmitate oxidation in isolated muscles
Experiments were conducted as previously described
(Dzamko et al. 2008; Steinberg et al. 2010). Briefly, mus-
cles were transferred to organ baths (Radnoti, Monrovia,
CA) filled with prewarmed (30°C) Krebs–Hanseleit basal
buffer (NaCl, 119 mmol/L; KCl, 4.7 mmol/L; CaCl2,
2.5 mmol/L; MgSO4, 1.2 mmol/L; KH2PO4, 1.2 mmol/L;
NaHCO3, 25 mmol/L) supplemented with pyruvate
(2.0 mmol/L), fatty acid free BSA (4%), and palmitate
(0.5 mmol/L) for 20 min. The distal tendon of the muscle
was tied to a fixed, immovable hook and the proximal
tendon was attached vertically to a force transducer
(Model TRI202P, PanLab, Barcelona, Spain). Incubation
chambers were oxygenated with 95% O2: 5% CO2 and
thermostatically maintained at 30°C. Gas supply to the
muscle was shut off and the buffer was replaced with a
similar buffer (0.5 mmol/L palmitate) supplemented with
[1-14C]-palmitic acid (0.5 lCi/mL for a specific activity
of ~830 dpm/nmol). One ml of mineral oil was placed on
top of tracer buffer to prevent 14CO2 loss during contrac-
tions. The muscles were stimulated with a series of iso-
metric twitch contractions, with muscle length adjusted
between responses to determine the optimum length
(Lo); the length at which twitch force was optimal.
Muscles were stimulated (50 Hz, 40V, 600 ms pulse dura-
tion, 6 tetani/min) for 20 min. This contraction protocol
has previously been shown to stimulate fatty acid oxida-
tion maximally during contractions of isolated muscles
(Dyck and Bonen 1998).
Analytical methods
Western blotting
Muscles lysates were prepared and subjected to Western
blotting as previously described (O’Neill et al. 2011). Pro-
tein phosphorylation and expression levels were deter-
mined by SDS-PAGE followed by immunoblotting using
muscle lysates that were adjusted to equal protein concen-
tration (2 lg/lL) and boiled for 5 min at 95°C in 49
sample buffer (TrisHCl [50 mmol/L, pH 6.8], SDS [2%],
glycerol [10%], DTT [1%], EDTA [1%], and bromophe-
nol blue [0.02%]). Primary antibodies for determination
of phosphorylation status and total expression of various
proteins are as follows: AMPK phospho-aT172 (#2531;
Cell Signaling Technology, Danvers, MA), ACC phospho-
S79 (also detects S221 site of ACC2 [S212 in mouse])
(#3661; Cell Signaling Technology), CPT-1 (CPT1M11-A;
Alpha Diagnostics, San Antonio, TX), sirtuin 3 (SIRT3)
(#86671; AbCam, Cambridge, UK) and uncoupling pro-
tein 3 (UCP3) (#3477; AbCam). Glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) (#9483; AbCam), a
actinin (# A7811; Sigma Aldrich, St Louis, MO),
pan actin (#8456; Cell Signaling Technology) or voltage-
dependent anion channel (#4866; Cell Signaling
Technology) were used as a protein loading control or
Steptavidin-HRP (#3999; Cell Signaling Technology) for
total ACC. Membranes were washed 3 9 10 min with
PBST and incubated with an appropriate HRP-conjugated
secondary antibody (1:10,000) for 1 h at room tempera-
ture. Protein bands were visualized using a Fusion Image
Dock Station (Vilber Lourmat, Eberhandzell, Germany)
and enhanced chemiluminescence (ECL+). Bands were
quantified using ImageJ software and protein content was
expressed in relative units in comparison with control
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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samples loaded on each gel or in the case of phosphory-
lated proteins as a ratio of the phosphorylated to total
protein (e.g., ACC-p S79/212/ACC). Membranes used for
detection of phosphorylated AMPK or ACC were stripped
with a buffer containing 2-mercaptoethanol (100 mmol/
L), SDS (2%), and Tris.HCl (62.5 mmol/L), pH 7.8.
Membranes were reprobed with the corresponding total
antibody or GAPDH.
ACC2 activity and Malonyl-CoA
ACC1 and ACC2 activity in gastrocnemius was measured
by 14CO2 fixation into acid-stable products as recently
described (Fullerton et al. 2013). Briefly, four 10 lL repli-
cates from each immunoprecipitated sample were incu-
bated for 30 min at room temperature with 90 lL reaction
buffer containing acetyl-CoA (125 lmol/L), [14C]-NaH-
CO3 (134 lCi/mL; equivalent to 2.5 mmol/L of NaHCO3)
(Cat# NEC086H001MC; Perkin Elmer, Waltham, MA),
HEPES (556 mmol/L), MgCl2 (111 mmol/L), MnCl2
(11 mmol/L), DTT (22 mmol/L), ATP (4 mmol/L), BSA
(0.0075%), and +/ citrate (5 mmol/L). The reaction was
stopped by the addition of 10 lL of concentrated HCl and
dried at 80°C. A second evaporation step was performed
to reduce intersample variability by the addition of 50 lL
of 5 mol/L HCl and evaporated at 80°C. 200 lL of H2O
was added to the dried sample and [14C] radioactivity
measured by liquid scintillation counting. Malonyl-CoA
was measured in extracts from gastrocnemius muscle of
fed mice using Ultra Performance Liquid Chromatography
(UPLC) as recently described (Fullerton et al. 2013).
Muscle glycogen and triglycerides
Glycogen content was determined in gastrocnemius mus-
cle as glycosyl units after acid hydrolysis as previously
described (Passonneau et al. 1967). Briefly, 10 mg w/w
muscle was hydrolyzed in HCl (1 mol/L) at 98°C for 2 h
and analyzed using an automatic analyzer (Hitachi auto-
matic analyzer 912; Boehringer Mannheim, Ingelheim,
Germany).
Statistics
Unless otherwise noted, data were expressed as
means  standard error of the mean (SEM). Results were
analyzed using Student’s t-test, paired t-test or analysis of
variance (ANOVA) procedures where appropriate using
GraphPad Prism software (La Jolla, CA). Significance was
accepted at P < 0.05.
Results
We first electrically stimulated extensor digitorium longus
(EDL) muscles from WT and ACC2-KI mice ex vivo and
found that there was no difference in fatigue curves
(Fig. 1A) or fatty acid oxidation (Fig. 1B) between geno-
types. Unfortunately given the small size of the EDL mus-
cle it was not possible to measure ACC activity or
malonyl-CoA following contractions. These data indicate
that a lack of ACC2 S212 phosphorylation does not pro-
mote muscle fatigue or reduce rates of fatty acid oxida-
tion during electrically stimulated contractions.
Given the artificial and intense nature of the ex vivo
muscle contraction protocol we next examined treadmill
running performance in WT and ACC2-KI mice and, to
test for potential compensation by ACC1, ACCD-KI mice.
We found that maximal treadmill running speed was not
different between genotypes (Fig. 2A). In subsequent
experiments we collected respiratory gases during endur-
ance treadmill running (60 min at same relative intensity
[65% each individual mouse’s maximal running speed])
and found that average RER and calculated fatty acid oxi-
dation (total lipids oxidized) for all mice were similar to
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Figure 1. ACC2 S212 phosphorylation is not essential for regulating muscle performance or rates of fatty acid oxidation during muscle
contractions. Force (A) and Palmitate oxidation (B) in extensor digitorum longus muscles from WT and ACC2 KI mice contracted ex vivo.
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WT (Fig. 2B and C). Oxygen consumption (VO2) and
carbon dioxide (CO2) production were not different from
WT (Fig. 2D and E). Circulating levels of glucose and lac-
tate were not different between genotypes; however, NEFA
levels were modestly reduced in ACC2 but not ACCD-KI
mice (Table 1). These data suggest that mice were exercis-
ing at the same relative intensity and the maintenance of
fatty acid oxidation in ACC2-KI mice was not due to
increased adipose lipolysis/substrate availability compared
to WT mice. Consistent with similar rates of fatty acid
oxidation during the treadmill exercise muscle glycogen
levels at the completion of exercise were also not different
between genotypes (Table 1). Collectively, these data indi-
cate that the phosphorylation of ACC1 Ser79 and ACC2
S212 is not required for maintaining endurance exercise
capacity or whole-body rates of fatty acid oxidation
during submaximal endurance exercise.
At the completion of the 60 min of treadmill exercise,
as described above, muscles were collected from WT,
ACC2-KI, and ACCD-KI mice. Treadmill exercise
increased activating phosphorylation of AMPK T172 in
WT mice and this was comparable in ACC2-KI mice,
but slightly reduced in ACCD-KI mice (Fig. 3A). The
reason for this reduction in AMPK activating phosphor-
ylation in ACCD-KI mice during treadmill running is
not known. While exercise increased ACCS79/212 phos-
phorylation in WT mice this was not observed in
ACC2-KI and ACCD-KI mice (Fig. 3B). We subse-
quently measured ACC1 and ACC2 activity in muscles
of ACC2-KI mice. We found that ACC1 activity in skel-
etal muscle was below the limits of detection of our
assay in both WT and ACC2-KI mice despite the assay
easily detecting ACC1-specific activity in liver samples
(data not shown and Fullerton et al. 2013). These find-
ings are consistent with previous reports that ACC1
activity is extremely low in skeletal muscle (Abu-Elheiga
et al. 1995). Given the undetectable levels of muscle
ACC1 activity further analysis was only conducted in
ACC2-KI mice. Consistent with our previous findings
(O’Neill et al. 2014) ACC2 activity tended to be upregu-
lated in resting muscles of ACC2-KI mice compared to
WT controls (Fig. 3C). Importantly, we found that at
the completion of exercise WT mice had reduced ACC2
activity but that this effect was blunted in ACC2-KI
mice (Fig. 3C). These data indicate that ACC2 S212
phosphorylation is essential for inhibiting ACC2 activity
during treadmill exercise. We subsequently examined
muscle malonyl-CoA in WT and ACC2-KI mice and
found that consistent with changes in ACC2 activity,
malonyl-CoA levels were reduced in WT but not
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ACC2-KI mice following the completion of exercise
(Fig. 3D). These data indicate that while ACC2 S212
phosphorylation is critical for regulating ACC2 activity
and malonyl-CoA content during exercise, this is not
required for regulating rates of fatty acid oxidation or
exercise capacity during treadmill running.
In an attempt to identify possible AMPK-ACC2-malo-
nyl-CoA independent mechanisms regulating fatty acid
oxidation during exercise we measured expression of pro-
teins that have been implicated in the regulation of skele-
tal muscle fatty acid oxidation. Given many recent reports
indicating a potentially important role for tre-2/USP6,
BUB2, cdc16 domain family member 1 (TBC1D1) in
inhibiting fatty acid oxidation (Chadt et al. 2008; Maher
et al. 2014) and potential regulation through AMPK
(O’Neill et al. 2011; Jeppesen et al. 2013; Fentz et al.
2015) we measured this protein and found no difference
compared to WT littermates (Fig. 4A). We also measured
the expression of mitochondrial proteins implicated in
the regulation of fatty acid oxidation (McGarry and
Brown 1997; MacLellan et al. 2005; Hirschey et al. 2010)
including CPT-1 (Fig. 4B), UCP3 (Fig. 4C), and SIRT3
(Fig. 4D) and found that the expression of these proteins
were not altered in muscle of ACC2-KI mice compared to
WT controls. These data suggest that the maintenance of
mitochondrial fatty acid oxidation in ACC2-KI mice dur-
ing exercise, despite elevated ACC2 activity and malonyl-
CoA, is not due to changes in the expression of TBC1D1,
CPT1, UCP3, or SIRT3.
Discussion
The AMPK-ACC2-malonyl-CoA signaling pathway has
been implicated as the principal mechanism regulating
fatty acid oxidation during exercise. This assumption has
been based on studies using pharmacological agents such
as AICAR and association studies during exercise showing
activation of AMPK is associated with increases in ACC
Ser79/212 phosphorylation and reductions in ACC activ-
ity and malonyl-CoA levels. Despite these strong associa-
tions previous studies in muscle AMPK deficient mouse
models mice display normal (Dzamko et al. 2008;
Steinberg et al. 2010; Jeppesen et al. 2013) or increased
(O’Neill et al. 2011) rates of fatty acid oxidation during
exercise/muscle contractions. However, a recent report in
AMPK alpha muscle-specific null mice has found lower
rates of fatty acid oxidation during exercise and muscle
contractions, but these findings are complicated by the
reduced mitochondrial function and lower rates of basal
fatty acid oxidation in this mouse model (Fentz et al.
2015). In addition, in this study surprisingly there was
also a substantial increase in ACC phosphorylation during
contraction making it difficult to make conclusions about
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the importance of this pathway in controlling fatty acid
oxidation during exercise/muscle contractions (Fentz
et al. 2015). Therefore, the goal of this study was to
examine the importance of the ACC-malonyl-CoA signal-
ling axis in regulating fatty acid oxidation during exercise.
We find that while ACC2 phosphorylation is essential for
controlling muscle ACC2 activity and malonyl-CoA con-
tent, surprisingly this is not vital for regulating rates of
fatty acid oxidation during exercise/muscle contractions.
In contrast to resting muscle where the AMPK-ACC-
malonyl-CoA signaling pathway is vital for controlling
rates of fatty acid oxidation (Fullerton et al. 2013; O’Neill
et al. 2014) we find that ACC2-KI mice had normal rates
of fatty acid oxidation when measured ex vivo during
muscle contractions or in vivo during treadmill exercise.
Importantly, despite high levels of malonyl-CoA, fatty
acid flux into the mitochondria is not altered, indicating
alternative pathways controlling fatty acid entry into the
mitochondria may exist. Therefore, we assessed the
expression of proteins implicated in the regulation of fatty
acid oxidation in muscle (TBC1D1, CPT1b, UCP3, and
SIRT3) and found their expression was not altered in
ACC2-KI mice. Further genomic and proteomic analysis
will need to be completed to examine whether there are
alterations in other proteins capable of regulating fatty
acid oxidation in muscle.
A second possibility for the maintenance of fatty acid
oxidation in ACC2-KI mice may be that CPT-1b becomes
insensitive to malonyl-CoA during exercise as previously
suggested (Bezaire et al. 2004; Kerner et al. 2004; Hollo-
way et al. 2006). Indeed our findings are consistent with
a report by Smith et al. (Smith et al. 2012) who have
established that the IC50 for malonyl-CoA inhibition of
CPT-1b is much higher than would be predicted to allow
for fatty acid oxidation during contractions. The reasons
why muscle contractions but not AMPK activators (such
as AICAR) may stimulate fatty acid oxidation indepen-
dent of the ACC2-malonyl-CoA pathway is currently
unclear. One hypothesis involves the idea that muscle
contractions may activate a distinct set of kinases, which
induce posttranslational modifications on CPT-1b that
are important for desensitizing the enzyme to malonyl-
CoA. For example Ca2+/calmodulin-dependent protein
kinase and protein kinase A may be activated with exer-
cise and could phosphorylate CPT-I to alter malonly-CoA
sensitivity and/or CPT-I activity (Kerner et al. 2004; Shar-
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Figure 3. ACC2 S212 phosphorylation inhibits ACC2 activity and malonyl-CoA production during exercise. Mixed gastrocnemius muscle (A)
AMPK T172 and (B) ACC2 S212 phosphorylation in ACC2-KI, ACCD-KI and WT mice at rest and following 60 min of submaximal treadmill
running (65% maximal running capacity) relative to WT mice. (C) Mixed gastrocnemius muscle (C) ACC2 activity (+/ 5 mmol/L citrate) and (D)
malonyl-CoA in WT and ACC2 KI mice at rest and following 60 min of submaximal treadmill running (65% maximal running capacity). Data
are means  SEM, n = 6–11. #P < 0.05 relative resting conditions, same genotype. *P < 0.05 compared to wild-type (WT) mice.
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ma et al. 2010; Lundby et al. 2013; O’Neill et al. 2013).
Future studies investigating this possibility may be impor-
tant for understanding the mechanisms regulating fatty
acid oxidation during exercise.
In addition to regulation by phosphorylation, lysine
acetylation is an alternative mechanism that has recently
been found to be important for regulating metabolism.
Like phosphorylation, lysine acetylation can regulate
enzyme activity of a range of proteins which are impor-
tant for controlling fatty acid oxidation (reviewed in (Gir-
alt and Villarroya 2012; Houtkooper et al. 2012). Indeed
a recent study has found that genetic deletion of ACC
results in alterations in acetylation profiles in the liver
(Chow et al. 2014). Future studies investigating acetyla-
tion profiles in muscle of WT and ACC2-KI mice with
and without exercise may reveal important new targets
for controlling fatty acid oxidation.
One limitation of our study is that red and white
muscle fiber types have differences in ACC activity, sen-
sitivity to malonyl-CoA and oxidative capacity (Winder
and Hardie 1996; Winder et al. 1997). We assessed
palmitate oxidation in the glycolytic EDL muscle but
due to the limited size of this muscle (~10 mg) it was
necessary to examine AMPK phosphorylation, ACC
activity and malonyl-CoA content in mixed gastrocne-
mius muscle, which is more oxidative. While the mixed
gastrocnemius muscle is more oxidative than EDL mus-
cle it should be noted that it is reflective of the majority
of the muscle mass in the mouse and as we also
observed normal rates of fatty acid oxidation during
whole body treadmill exercise our findings between these
two muscle types appear to be consistent with the main-
tenance of fatty acid oxidation in the absence of ACC
phosphorylation. A second limitation of our study was
that it is possible that ACC KI mice have developed
compensatory adaptations and phenotypes leading to
masking or distortion of the acute role of this protein
in regulating fatty acid oxidation (Barbaric et al. 2007).
While in contrast to most genetic null models which
remove the entire protein the mutations in our study
were much more subtle and involved mutation of a
single amino acid in either ACC1 and ACC2 proteins
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Figure 4. Expression of proteins involved in fatty acid oxidation in muscle. (A) TBC1D1 protein expression in quadriceps muscle of WT and
ACC2 KI mice (N = 8–10). (B) CPT-1 expression in gastrocnemius muscle (N = 5–7). (C) UCP3 and (D) SIRT3 protein expression in quadriceps
muscle (N = 8–10). Data are means  SEM.
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(Fullerton et al. 2013). However, we cannot rule out the
possibility that compensatory upregulation of alternative
pathways may have occurred masking the importance of
this pathway in controlling fatty acid oxidation during
exercise. Further proteomic studies may provide greater
insight into the role of these compensatory pathways in
regulating fatty acid oxidation.
In conclusion our studies indicate that during exercise/
muscle contractions ACC2 phosphorylation is not vital
for controlling rates of fatty acid oxidation. These studies
highlight the important role of physiological redundancy
in regulating metabolic flux during exercise and indicate
that alternative pathways may be important. Future stud-
ies involving phosphoproteomic and acetylation profiling
to identify ACC2-malonyl-CoA independent pathways
will be necessary for understanding how fatty acid oxida-
tion is regulated during exercise.
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